+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Obsessive Compulsive Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Obsessive Compulsive Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Bleeding Disorders Treatment - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorders Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Global Markets for Blood Plasma Products - Product Thumbnail Image

Global Markets for Blood Plasma Products

  • Report
  • February 2023
  • 144 Pages
  • Global
From
Coagulation Factor Concentrates - Global Strategic Business Report - Product Thumbnail Image

Coagulation Factor Concentrates - Global Strategic Business Report

  • Report
  • November 2024
  • 129 Pages
  • Global
From
Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
Thrombin - Global Strategic Business Report - Product Thumbnail Image

Thrombin - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Plasma Therapy - Global Strategic Business Report - Product Thumbnail Image

Plasma Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 179 Pages
  • Global
From
From
From
From
Loading Indicator